Correlation of emPHasis-10 with clinical tests: insights from the ASPIRE registry
S. Alabed (Sheffield, United Kingdom), K. Dwivedi (Sheffield, United Kingdom), C. Durrington (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), R. Lewis (Sheffield, United Kingdom), C. Eelliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), R. Thompson (Sheffield, United Kingdom), A. Hameed (Sheffield, United Kingdom), A. Rothman (Sheffield, United Kingdom), I. Armstrong (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom)
Source: International Congress 2022 – Risk assessment in pulmonary arterial hypertension
Session: Risk assessment in pulmonary arterial hypertension
Session type: Thematic Poster
Number: 462
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Alabed (Sheffield, United Kingdom), K. Dwivedi (Sheffield, United Kingdom), C. Durrington (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), R. Lewis (Sheffield, United Kingdom), C. Eelliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), R. Thompson (Sheffield, United Kingdom), A. Hameed (Sheffield, United Kingdom), A. Rothman (Sheffield, United Kingdom), I. Armstrong (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom). Correlation of emPHasis-10 with clinical tests: insights from the ASPIRE registry. 462
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|